Cargando…

Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial

BACKGROUND: The treatment of Leishmaniasis caused by Leishmania (Viannia) guyanensis is based on a weak strength of evidence from very few clinical trials and some case series reports. Current treatment guidelines recommend pentamidine isethionate or meglumine antimoniate (Glucantime) as the first-l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francesconi, Valeska Albuquerque, Francesconi, Fabio, Ramasawmy, Rajendranath, Romero, Gustavo Adolfo Sierra, Alecrim, Maria das Graças Costa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854414/ https://www.ncbi.nlm.nih.gov/pubmed/29481560 http://dx.doi.org/10.1371/journal.pntd.0006225

Ejemplares similares

Intercalated low doses of antimonials for disseminated cutaneous leishmaniasis caused by Leishmania guyanensis: A successful approach in Amazonas, Brazil
por: Monçale Campos, Aline Grasielli, et al.
Publicado: (2018)

Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Guerra, Jorge Augusto de Oliveira, et al.
Publicado: (2011)

Polymorphisms in the TOLLIP Gene Influence Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis in the Amazonas State of Brazil
por: de Araujo, Felipe Jules, et al.
Publicado: (2015)

Mutilating localized cutaneous leishmaniasis caused by Leishmania guyanensis()
por: Silva, Dina Fabrício da, et al.
Publicado: (2023)

Distinct plasma chemokines and cytokines signatures in Leishmania guyanensis-infected patients with cutaneous leishmaniasis
por: de Mesquita, Tirza Gabrielle Ramos, et al.
Publicado: (2022)

Variants of NOD2 in Leishmania guyanensis-infected patients with cutaneous leishmaniasis and correlations with plasma circulating pro-inflammatory cytokines
por: de Mesquita, Tirza Gabrielle Ramos, et al.
Publicado: (2023)

First Report of Canine Infection by Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Santos, Francisco J. A., et al.
Publicado: (2020)

Leishmania (Viannia) guyanensis Causing Localized Cutaneous Leishmaniasis in a Traveler
por: Motie, Ian K, et al.
Publicado: (2022)

Lobomycosis: epidemiology, clinical presentation, and management options
por: Francesconi, Valeska Albuquerque, et al.
Publicado: (2014)

Single nucleotide polymorphisms of the genes IL-2, IL-2RB, and JAK3 in patients with cutaneous leishmaniasis caused by Leishmania (V.) guyanensis in Manaus, Amazonas, Brazil
por: de Araújo Santos, Felipe Jules, et al.
Publicado: (2019)

Molecular tools confirm natural Leishmania (Viannia) guyanensis/L. (V.) shawi hybrids causing cutaneous leishmaniasis in the Amazon region of Brazil
por: Lima, Ana Carolina S., et al.
Publicado: (2021)

Variants of CARD8 in Leishmania guyanensis-cutaneous leishmaniasis and influence of the variants genotypes on circulating plasma cytokines IL-1β, TNFα and IL-8
por: Sequera, Héctor David Graterol, et al.
Publicado: (2023)

Multiple evolutionary lineages for the main vector of Leishmania guyanensis, Lutzomyia umbratilis (Diptera: Psychodidae), in the Brazilian Amazon
por: Scarpassa, Vera Margarete, et al.
Publicado: (2021)

Therapy of cutaneous leishmaniasis caused by Leishmania braziliensis with fluconazole
por: Veraldi, Stefano, et al.
Publicado: (2021)

Variants of MIRNA146A rs2910164 and MIRNA499 rs3746444 are associated with the development of cutaneous leishmaniasis caused by Leishmania guyanensis and with plasma chemokine IL-8
por: de Mesquita, Tirza Gabrielle Ramos, et al.
Publicado: (2021)

Publisher Correction: Multiple evolutionary lineages for the main vector of Leishmania guyanensis, Lutzomyia umbratilis (Diptera: Psychodidae), in the Brazilian Amazon
por: Scarpassa, Vera Margarete, et al.
Publicado: (2021)

TREM1 rs2234237 (Thr25Ser) Polymorphism in Patients with Cutaneous Leishmaniasis Caused by Leishmania guyanensis: A Case-Control Study in the State of Amazonas, Brazil
por: do Espírito Santo Júnior, José, et al.
Publicado: (2021)

A fine mapping of single nucleotide variants and haplotype analysis of IL13 gene in patients with Leishmania guyanensis-cutaneous leishmaniasis and plasma cytokines IL-4, IL-5, and IL-13
por: Junior, José do Espírito Santo, et al.
Publicado: (2023)

Phenotypic characterization of Leishmania spp. causing cutaneous leishmaniasis in the lower Amazon region, western Pará state, Brazil, reveals a putative hybrid parasite, Leishmania (Viannia) guyanensis × Leishmania (Viannia) shawi shawi
por: Jennings, Yara Lins, et al.
Publicado: (2014)

Leishmania (Viannia) braziliensis type 2 as probable etiological agent of canine cutaneous leishmaniasis in Brazilian Amazon
por: Brilhante, Andreia Fernandes, et al.
Publicado: (2019)

Insights on Host–Parasite Immunomodulation Mediated by Extracellular Vesicles of Cutaneous Leishmania shawi and Leishmania guyanensis
por: Weber, Juliana Inês, et al.
Publicado: (2023)

Leishmania (Viannia) guyanensis Infection, Austria
por: Poeppl, Wolfgang, et al.
Publicado: (2012)

Filling the gaps in Leishmania naiffi and Leishmania guyanensis genome plasticity
por: Patiño, Luz H, et al.
Publicado: (2021)

Chloroquine-Resistant Plasmodium vivax, Brazilian Amazon
por: Filho, Franklin Simoes de Santana, et al.
Publicado: (2007)

Leishmania braziliensis isolated from disseminated leishmaniasis patients downmodulate neutrophil function
por: Cardoso, Thiago, et al.
Publicado: (2019)

Insights from Leishmania (Viannia) guyanensis in vitro behavior and intercellular communication
por: Pereira, Luiza O. R., et al.
Publicado: (2021)

Glucose-6-Phosphate Dehydrogenase Deficiency in an Endemic Area for Malaria in Manaus: A Cross-Sectional Survey in the Brazilian Amazon
por: Santana, Marli Stela, et al.
Publicado: (2009)

Severe Plasmodium vivax Malaria, Brazilian Amazon
por: Alexandre, Márcia A., et al.
Publicado: (2010)

Natural Leishmania (Viannia) spp. infections in phlebotomine sand flies (Diptera: Psychodidae) from the Brazilian Amazon region reveal new putative transmission cycles of American cutaneous leishmaniasis
por: de Souza, Adelson Alcimar Almeida, et al.
Publicado: (2016)

First report of Leishmania (Viannia) lindenbergi causing tegumentary leishmaniasis in the Brazilian western Amazon region
por: Cantanhêde, Lilian Motta, et al.
Publicado: (2019)

Diagnosis and identification of Leishmania species in patients with cutaneous leishmaniasis in the state of Roraima, Brazil's Amazon Region
por: de Almeida, Joseneide Viana, et al.
Publicado: (2021)

Characterization of Leishmania spp. causing cutaneous leishmaniasis in Manaus, Amazonas, Brazil
por: Camara Coelho, Leila Ines, et al.
Publicado: (2010)

Leishmania naiffi and Leishmania guyanensis reference genomes highlight genome structure and gene evolution in the Viannia subgenus
por: Coughlan, Simone, et al.
Publicado: (2018)

Cutaneous Leishmaniasis Due to Leishmania aethiopica
por: van Henten, Saskia, et al.
Publicado: (2019)

Identification and Biological Characterization of Leishmania (Viannia) guyanensis Isolated from a Patient with Tegumentary Leishmaniasis in Goiás, a Nonendemic Area for This Species in Brazil
por: Pires, Alause da Silva, et al.
Publicado: (2015)

Distinct Macrophage Fates after in vitro Infection with Different Species of Leishmania: Induction of Apoptosis by Leishmania (Leishmania) amazonensis, but Not by Leishmania (Viannia) guyanensis
por: DaMata, Jarina Pena, et al.
Publicado: (2015)

Disseminated Cutaneous Leishmaniasis, a Patient with 178 Lesions Cured with Fluconazole
por: Sousa, Anastácio Queiroz, et al.
Publicado: (2016)

Alleles of HLA-DRB1*04 Associated with Pulmonary Tuberculosis in Amazon Brazilian Population
por: Souza de Lima, Dhêmerson, et al.
Publicado: (2016)

Lutzomyia umbratilis, the Main Vector of Leishmania guyanensis, Represents a Novel Species Complex?
por: Scarpassa, Vera Margarete, et al.
Publicado: (2012)

Leishmania guyanensis parasites block the activation of the inflammasome by inhibiting maturation of IL-1β
por: Hartley, Mary-Anne, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_epnm8dcn2csma0pq6jud87dtd4